article thumbnail

Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review

Drug Patent Watch

International License Abstract Development of generic drug product…. This paper was originally published by Md. Imtiaz Hasan et al in Journal of Biosciences and Medicines under a Creative Commons Attribution 4.0

article thumbnail

Common Drugs with Effective Off-Label Uses

Drug Patent Watch

Mudawi in the Journal of Pharmaceutical Research International under the terms of the Creative Commons Attribution License.…. This article was originally published by Mohammed M. Alshehri and Mahmoud M. The post Common Drugs with Effective Off-Label Uses appeared first on DrugPatentWatch - Make Better Decisions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Expanded Access to Rabies Plasmids

addgene Blog

Addgene is excited to announce we now offer an export license application for rabies materials! The export license, if granted, allows us to ship rabies plasmids and viral vectors containing genetic elements from rabies plasmids to international requestors.

article thumbnail

PFIZER AND THE MEDICINES PATENT POOL (MPP) SIGN LICENSING AGREEMENT FOR COVID-19 ORAL ANTIVIRAL TREATMENT CANDIDATE TO EXPAND ACCESS IN LOW- AND MIDDLE-INCOME COUNTRIES

The Pharma Data

The agreement will enable MPP to grease fresh product and distribution of the investigational antiviral, pending nonsupervisory authorization or blessing, by grantingsub-licenses to good general drug manufacturers, with the thing of easing lesser access to the global population. This press release features multimedia.

article thumbnail

Nobel Prize celebrates AI’s role in protein structure innovation

Drug Target Review

DeepMind filed three international (PCT) applications in 2019, which cover relatively broad methods of generating multiple structural predictions, updating parameters using neural networks, and selecting the final structure.

article thumbnail

Women in STEM with Kristina Torfgard

Drug Target Review

This role gave me a good understanding of how important IP/patent and global marketing are for the brand but also the importance of emerging markets and co-development and out-licensing to other pharma companies. I experienced challenges in cultural differences working with US, UK, Japan, and China.

article thumbnail

Dragonfly Therapeutics and Bristol Myers Squibb Announce Exclusive Global License for Dragonfly’s IL-12 Investigational Immunotherapy Program

The Pharma Data

DF6002 is a monovalent IL-12 immunoglobulin Fc fusion protein proposed to achieve strong anti-tumor efficacy by establishing an inflammatory tumor microenvironment necessary for productive anti-tumor responses.